Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as
well as for assessing the therapeutic efficacy of a cancer treatment and determining whether
a subject potentially is developing cancer. Associated test kits, computer and analytical
systems as well as software and diagnostic models are also provided.